HIGHLIGHTS
- who: Elizabeth Smyth from the Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK have published the research: ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial, in the Journal: (JOURNAL) of 01/Oct/2020
- what: The aim is to determine the activity of maintenance TMZ dosing followed by nivolumab treatment to evaluate the potential for a future randomised trial against a standard of care control arm. Withdrawal criteria Participants are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.